{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T07:49:53Z","timestamp":1785656993750,"version":"3.56.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG060882"],"award-info":[{"award-number":["P01AG060882"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072979"],"award-info":[{"award-number":["P30AG072979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG060882"],"award-info":[{"award-number":["P01AG060882"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02844-z","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T05:10:26Z","timestamp":1737177026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer\u2019s disease, and late-onset Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"149","author":[{"given":"Mitchell","family":"Mart\u00e1-Ariza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique F.","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Kanshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianina","family":"Suazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Giusti Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Ueberheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"2844_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104603","author":"AC Aladeokin","year":"2019","unstructured":"Aladeokin AC, Akiyama T, Kimura A, Kimura Y, Takahashi-Jitsuki A, Nakamura H et al (2019) Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Abeta in a mice model of early-stage Alzheimer\u2019s disease. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2019.104603","journal-title":"Neurobiol Dis"},{"key":"2844_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13692","author":"I Aldecoa","year":"2024","unstructured":"Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD et al (2024) Down Syndrome biobank consortium: a perspective. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13692","journal-title":"Alzheimers Dement"},{"key":"2844_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW et al (2020) Down syndrome. Nat Rev Dis Primers 6:9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7","journal-title":"Nat Rev Dis Primers"},{"key":"2844_CR4","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi M, Kavanagh T, Pires G, Ueberheide B, Wisniewski T, Drummond E (2023) Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat Commun 14:4466. https:\/\/doi.org\/10.1038\/s41467-023-40208-x","journal-title":"Nat Commun"},{"key":"2844_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00401-024-02819-6","volume":"148","author":"K Balcomb","year":"2024","unstructured":"Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G et al (2024) SMOC1 colocalizes with Alzheimer\u2019s disease neuropathology and delays Abeta aggregation. Acta Neuropathol 148:72. https:\/\/doi.org\/10.1007\/s00401-024-02819-6","journal-title":"Acta Neuropathol"},{"key":"2844_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2990.2006.00756.x","volume":"32","author":"M Barrachina","year":"2006","unstructured":"Barrachina M, Maes T, Buesa C, Ferrer I (2006) Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 32:505\u2013516. https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00756.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2844_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020817","author":"AF Batista","year":"2024","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA (2024) The importance of complement-mediated immune signaling in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25020817","journal-title":"Int J Mol Sci"},{"key":"2844_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41593-022-01166-7","volume":"25","author":"J Bendl","year":"2022","unstructured":"Bendl J, Hauberg ME, Girdhar K, Im E, Vicari JM, Rahman S et al (2022) The three-dimensional landscape of cortical chromatin accessibility in Alzheimer\u2019s disease. Nat Neurosci 25:1366\u20131378. https:\/\/doi.org\/10.1038\/s41593-022-01166-7","journal-title":"Nat Neurosci"},{"key":"2844_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"2018","unstructured":"Benjamini Y, Hochberg Y (2018) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"2844_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-023-01206-2","volume":"15","author":"A Boeddrich","year":"2023","unstructured":"Boeddrich A, Haenig C, Neuendorf N, Blanc E, Ivanov A, Kirchner M et al (2023) A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer\u2019s disease. Genome Med 15:50. https:\/\/doi.org\/10.1186\/s13073-023-01206-2","journal-title":"Genome Med"},{"key":"2844_CR11","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/cne.22379","volume":"518","author":"MP Bowley","year":"2010","unstructured":"Bowley MP, Cabral H, Rosene DL, Peters A (2010) Age changes in myelinated nerve fibers of the cingulate bundle and corpus callosum in the rhesus monkey. J Comp Neurol 518:3046\u20133064. https:\/\/doi.org\/10.1002\/cne.22379","journal-title":"J Comp Neurol"},{"key":"2844_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"key":"2844_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-5793(95)01298-2","volume":"377","author":"S Brandt","year":"1995","unstructured":"Brandt S, Jentsch TJ (1995) ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett 377:15\u201320. https:\/\/doi.org\/10.1016\/0014-5793(95)01298-2","journal-title":"FEBS Lett"},{"key":"2844_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ajhg.2022.02.001","volume":"109","author":"M Broly","year":"2022","unstructured":"Broly M, Polevoda BV, Awayda KM, Tong N, Lentini J, Besnard T et al (2022) THUMPD1 bi-allelic variants cause loss of tRNA acetylation and a syndromic neurodevelopmental disorder. Am J Hum Genet 109:587\u2013600. https:\/\/doi.org\/10.1016\/j.ajhg.2022.02.001","journal-title":"Am J Hum Genet"},{"key":"2844_CR15","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","volume":"1852","author":"J Carcel-Trullols","year":"2015","unstructured":"Carcel-Trullols J, Kovacs AD, Pearce DA (2015) Cell biology of the NCL proteins: What they do and don\u2019t do. Biochim Biophys Acta 1852:2242\u20132255. https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.027","journal-title":"Biochim Biophys Acta"},{"key":"2844_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-7704-8_3","volume":"1750","author":"JI Castrillo","year":"2018","unstructured":"Castrillo JI, Lista S, Hampel H, Ritchie CW (2018) Systems biology methods for Alzheimer\u2019s disease research toward molecular signatures, subtypes, and stages and precision medicine: application in cohort studies and trials. Methods Mol Biol 1750:31\u201366. https:\/\/doi.org\/10.1007\/978-1-4939-7704-8_3","journal-title":"Methods Mol Biol"},{"key":"2844_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0896-6273(95)90324-0","volume":"14","author":"AM Cataldo","year":"1995","unstructured":"Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S et al (1995) Gene expression and cellular content of cathepsin D in Alzheimer\u2019s disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14:671\u2013680. https:\/\/doi.org\/10.1016\/0896-6273(95)90324-0","journal-title":"Neuron"},{"key":"2844_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0006-8993(94)91858-9","volume":"640","author":"AM Cataldo","year":"1994","unstructured":"Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640:68\u201380. https:\/\/doi.org\/10.1016\/0006-8993(94)91858-9","journal-title":"Brain Res"},{"key":"2844_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157:277\u2013286. https:\/\/doi.org\/10.1016\/s0002-9440(10)64538-5","journal-title":"Am J Pathol"},{"key":"2844_CR20","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/j.1582-4934.2012.01604.x","volume":"16","author":"Y Chen","year":"2012","unstructured":"Chen Y, Neve RL, Liu H (2012) Neddylation dysfunction in Alzheimer\u2019s disease. J Cell Mol Med 16:2583\u20132591. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01604.x","journal-title":"J Cell Mol Med"},{"key":"2844_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nn.2240","volume":"12","author":"JS Cheng","year":"2009","unstructured":"Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu GQ et al (2009) Collagen VI protects neurons against Abeta toxicity. Nat Neurosci 12:119\u2013121. https:\/\/doi.org\/10.1038\/nn.2240","journal-title":"Nat Neurosci"},{"key":"2844_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF00296787","volume":"83","author":"NH Choi-Miura","year":"1992","unstructured":"Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, Tobe T et al (1992) SP-40,40 is a constituent of Alzheimer\u2019s amyloid. Acta Neuropathol 83:260\u2013264. https:\/\/doi.org\/10.1007\/BF00296787","journal-title":"Acta Neuropathol"},{"key":"2844_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","volume":"6","author":"YS Davidson","year":"2018","unstructured":"Davidson YS, Robinson A, Prasher VP, Mann DMA (2018) The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun 6:56. https:\/\/doi.org\/10.1186\/s40478-018-0559-4","journal-title":"Acta Neuropathol Commun"},{"key":"2844_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG (2017) Estimation of the number of people with Down syndrome in the United States. Genet Med 19:439\u2013447. https:\/\/doi.org\/10.1038\/gim.2016.127","journal-title":"Genet Med"},{"key":"2844_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s Disease. Cell 164:603\u2013615. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056","journal-title":"Cell"},{"key":"2844_CR26","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O\u2019Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR et al (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 99:10843\u201310848. https:\/\/doi.org\/10.1073\/pnas.162228299","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T et al (2023) Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer\u2019s disease. Nature 618:349\u2013357. https:\/\/doi.org\/10.1038\/s41586-023-06120-6","journal-title":"Nature"},{"key":"2844_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1074\/mcp.TIR119.001616","volume":"19","author":"J Doellinger","year":"2020","unstructured":"Doellinger J, Schneider A, Hoeller M, Lasch P (2020) Sample preparation by easy extraction and digestion (SPEED): a universal, rapid, and detergent-free protocol for proteomics based on acid extraction. Mol Cell Proteomics 19:209\u2013222. https:\/\/doi.org\/10.1074\/mcp.TIR119.001616","journal-title":"Mol Cell Proteomics"},{"key":"2844_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/ADR-170051","volume":"2","author":"L Dolfe","year":"2018","unstructured":"Dolfe L, Tambaro S, Tigro H, Del Campo M, Hoozemans JJM, Wiehager B et al (2018) The Bri2 and Bri3 BRICHOS domains interact differently with Abeta(42) and Alzheimer Amyloid Plaques. J Alzheimers Dis Rep 2:27\u201339. https:\/\/doi.org\/10.3233\/ADR-170051","journal-title":"J Alzheimers Dis Rep"},{"key":"2844_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","volume":"56","author":"E Doran","year":"2017","unstructured":"Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M et al (2017) Down Syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP. J Alzheimers Dis 56:459\u2013470. https:\/\/doi.org\/10.3233\/JAD-160836","journal-title":"J Alzheimers Dis"},{"key":"2844_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","volume":"10","author":"E Drummond","year":"2022","unstructured":"Drummond E, Kavanagh T, Pires G, Marta-Ariza M, Kanshin E, Nayak S et al (2022) The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome. Acta Neuropathol Commun 10:53. https:\/\/doi.org\/10.1186\/s40478-022-01356-1","journal-title":"Acta Neuropathol Commun"},{"key":"2844_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncb960","volume":"5","author":"D Edbauer","year":"2003","unstructured":"Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution of gamma-secretase activity. Nat Cell Biol 5:486\u2013488. https:\/\/doi.org\/10.1038\/ncb960","journal-title":"Nat Cell Biol"},{"key":"2844_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-024-01252-3","author":"A Fernandez","year":"2024","unstructured":"Fernandez A, Hoq MR, Hallinan GI, Li D, Bharath SR, Vago FS et al (2024) Cryo-EM structures of amyloid-beta and tau filaments in Down syndrome. Nat Struct Mol Biol. https:\/\/doi.org\/10.1038\/s41594-024-01252-3","journal-title":"Nat Struct Mol Biol"},{"key":"2844_CR34","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","volume":"143","author":"L Flores-Aguilar","year":"2020","unstructured":"Flores-Aguilar L, Iulita MF, Kovecses O, Torres MD, Levi SM, Zhang Y et al (2020) Evolution of neuroinflammation across the lifespan of individuals with Down syndrome. Brain 143:3653\u20133671. https:\/\/doi.org\/10.1093\/brain\/awaa326","journal-title":"Brain"},{"key":"2844_CR35","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","volume":"24","author":"MI Fonseca","year":"2004","unstructured":"Fonseca MI, Zhou J, Botto M, Tenner AJ (2004) Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer\u2019s disease. J Neurosci 24:6457\u20136465. https:\/\/doi.org\/10.1523\/JNEUROSCI.0901-04.2004","journal-title":"J Neurosci"},{"key":"2844_CR36","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","volume":"395","author":"J Fortea","year":"2020","unstructured":"Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I et al (2020) Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study. Lancet 395:1988\u20131997. https:\/\/doi.org\/10.1016\/S0140-6736(20)30689-9","journal-title":"Lancet"},{"key":"2844_CR37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M (2021) Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol 20:930\u2013942. https:\/\/doi.org\/10.1016\/S1474-4422(21)00245-3","journal-title":"Lancet Neurol"},{"key":"2844_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12903","author":"C Franceschi","year":"2019","unstructured":"Franceschi C, Garagnani P, Gensous N, Bacalini MG, Conte M, Salvioli S (2019) Accelerated bio-cognitive aging in Down syndrome: state of the art and possible deceleration strategies. Aging Cell. https:\/\/doi.org\/10.1111\/acel.12903","journal-title":"Aging Cell"},{"issue":"reviews0002","key":"2844_CR39","doi-asserted-by":"publisher","first-page":"0001","DOI":"10.1186\/gb-2000-1-2-reviews0002","volume":"1","author":"K Gardiner","year":"2000","unstructured":"Gardiner K, Davisson M (2000) The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol 1(reviews0002):0001. https:\/\/doi.org\/10.1186\/gb-2000-1-2-reviews0002","journal-title":"Genome Biol"},{"key":"2844_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291x(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease and Down\u2019s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131\u20131135. https:\/\/doi.org\/10.1016\/0006-291x(84)91209-9","journal-title":"Biochem Biophys Res Commun"},{"key":"2844_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0006-291x(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890. https:\/\/doi.org\/10.1016\/s0006-291x(84)80190-4","journal-title":"Biochem Biophys Res Commun"},{"key":"2844_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15\u201320. https:\/\/doi.org\/10.1016\/s0002-9440(10)64700-1","journal-title":"Am J Pathol"},{"key":"2844_CR43","doi-asserted-by":"publisher","first-page":"E3699","DOI":"10.1073\/pnas.1510329112","volume":"112","author":"S Gowrishankar","year":"2015","unstructured":"Gowrishankar S, Yuan P, Wu Y, Schrag M, Paradise S, Grutzendler J et al (2015) Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer\u2019s disease amyloid plaques. Proc Natl Acad Sci U S A 112:E3699-3708. https:\/\/doi.org\/10.1073\/pnas.1510329112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR44","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.0501823102","volume":"102","author":"S Grau","year":"2005","unstructured":"Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M et al (2005) Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci U S A 102:6021\u20136026. https:\/\/doi.org\/10.1073\/pnas.0501823102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","volume":"267","author":"SG Greenberg","year":"1992","unstructured":"Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564\u2013569","journal-title":"J Biol Chem"},{"key":"2844_CR46","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1093\/hmg\/ddy308","volume":"27","author":"EF Griffin","year":"2018","unstructured":"Griffin EF, Yan X, Caldwell KA, Caldwell GA (2018) Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer\u2019s and Parkinson\u2019s disease models of neurodegeneration. Hum Mol Genet 27:4176\u20134193. https:\/\/doi.org\/10.1093\/hmg\/ddy308","journal-title":"Hum Mol Genet"},{"key":"2844_CR47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322\u2013325. https:\/\/doi.org\/10.1038\/359322a0","journal-title":"Nature"},{"key":"2844_CR48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuroscience.2012.07.038","volume":"223","author":"DM Hafez","year":"2012","unstructured":"Hafez DM, Huang JY, Richardson JC, Masliah E, Peterson DA, Marr RA (2012) F-spondin gene transfer improves memory performance and reduces amyloid-beta levels in mice. Neuroscience 223:465\u2013472. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.07.038","journal-title":"Neuroscience"},{"key":"2844_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12987-022-00351-x","volume":"19","author":"T Handa","year":"2022","unstructured":"Handa T, Sasaki H, Takao M, Tano M, Uchida Y (2022) Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method. Fluids Barriers CNS 19:56. https:\/\/doi.org\/10.1186\/s12987-022-00351-x","journal-title":"Fluids Barriers CNS"},{"key":"2844_CR50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","volume":"11","author":"D Hartley","year":"2015","unstructured":"Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K et al (2015) Down syndrome and Alzheimer\u2019s Disease: common pathways, common goals. Alzheimers Dement 11:700\u2013709","journal-title":"Alzheimers Dement"},{"key":"2844_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s40478-020-01075-5","volume":"8","author":"T Hashimoto","year":"2020","unstructured":"Hashimoto T, Fujii D, Naka Y, Kashiwagi-Hakozaki M, Matsuo Y, Matsuura Y et al (2020) Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-beta plaques. Acta Neuropathol Commun 8:212. https:\/\/doi.org\/10.1186\/s40478-020-01075-5","journal-title":"Acta Neuropathol Commun"},{"key":"2844_CR52","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/ejn.13913","volume":"47","author":"S Hassiotis","year":"2018","unstructured":"Hassiotis S, Manavis J, Blumbergs PC, Hattersley KJ, Carosi JM, Kamei M et al (2018) Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus. Eur J Neurosci 47:1043\u20131053. https:\/\/doi.org\/10.1111\/ejn.13913","journal-title":"Eur J Neurosci"},{"key":"2844_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1567205012666151020114607","volume":"13","author":"E Head","year":"2016","unstructured":"Head E, Lott IT, Wilcock DM, Lemere CA (2016) Aging in Down syndrome and the development of Alzheimer\u2019s disease neuropathology. Curr Alzheimer Res 13:18\u201329. https:\/\/doi.org\/10.2174\/1567205012666151020114607","journal-title":"Curr Alzheimer Res"},{"key":"2844_CR54","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R (2015) InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics 16:169. https:\/\/doi.org\/10.1186\/s12859-015-0611-3","journal-title":"BMC Bioinformatics"},{"key":"2844_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9360","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M et al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aaz9360","journal-title":"Sci Adv"},{"key":"2844_CR56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352:712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"2844_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-015-0041-1","volume":"4","author":"YB Hu","year":"2015","unstructured":"Hu YB, Dammer EB, Ren RJ, Wang G (2015) The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl Neurodegener 4:18. https:\/\/doi.org\/10.1186\/s40035-015-0041-1","journal-title":"Transl Neurodegener"},{"key":"2844_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1925","author":"E Im","year":"2023","unstructured":"Im E, Jiang Y, Stavrides PH, Darji S, Erdjument-Bromage H, Neubert TA et al (2023) Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP betaCTF. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.adg1925","journal-title":"Sci Adv"},{"key":"2844_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ymgme.2018.03.007","volume":"124","author":"R Itagaki","year":"2018","unstructured":"Itagaki R, Endo M, Yanagisawa H, Hossain MA, Akiyama K, Yaginuma K et al (2018) Characteristics of PPT1 and TPP1 enzymes in neuronal ceroid lipofuscinosis (NCL) 1 and 2 by dried blood spots (DBS) and leukocytes and their application to newborn screening. Mol Genet Metab 124:64\u201370. https:\/\/doi.org\/10.1016\/j.ymgme.2018.03.007","journal-title":"Mol Genet Metab"},{"key":"2844_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1432-1327.1998.2520290.x","volume":"252","author":"I Janoueix-Lerosey","year":"1998","unstructured":"Janoueix-Lerosey I, Pasheva E, de Tand MF, Tavitian A, de Gunzburg J (1998) Identification of a specific effector of the small GTP-binding protein Rap2. Eur J Biochem 252:290\u2013298. https:\/\/doi.org\/10.1046\/j.1432-1327.1998.2520290.x","journal-title":"Eur J Biochem"},{"key":"2844_CR61","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","volume":"107","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer-Boiteau A et al (2010) Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A 107:1630\u20131635. https:\/\/doi.org\/10.1073\/pnas.0908953107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR62","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","volume":"39","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sato Y, Im E, Berg M, Bordi M, Darji S et al (2019) Lysosomal dysfunction in Down syndrome Is APP-dependent and mediated by APP-betaCTF (C99). J Neurosci 39:5255\u20135268. https:\/\/doi.org\/10.1523\/JNEUROSCI.0578-19.2019","journal-title":"J Neurosci"},{"key":"2844_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y et al (2022) Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci 25:213\u2013225. https:\/\/doi.org\/10.1038\/s41593-021-00999-y","journal-title":"Nat Neurosci"},{"key":"2844_CR64","doi-asserted-by":"publisher","first-page":"15602","DOI":"10.1021\/bi051263e","volume":"44","author":"H Kakuyama","year":"2005","unstructured":"Kakuyama H, Soderberg L, Horigome K, Winblad B, Dahlqvist C, Naslund J et al (2005) CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation. Biochemistry 44:15602\u201315609. https:\/\/doi.org\/10.1021\/bi051263e","journal-title":"Biochemistry"},{"key":"2844_CR65","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH et al (1987) The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733\u2013736. https:\/\/doi.org\/10.1038\/325733a0","journal-title":"Nature"},{"key":"2844_CR66","doi-asserted-by":"publisher","first-page":"2158285","DOI":"10.1080\/15592294.2022.2158285","volume":"18","author":"IK Karlsson","year":"2023","unstructured":"Karlsson IK, Ploner A, Wang Y, Gatz M, Pedersen NL, Hagg S (2023) Leukocyte DNA methylation in Alzheimer s disease associated genes: replication of findings from neuronal cells. Epigenetics 18:2158285. https:\/\/doi.org\/10.1080\/15592294.2022.2158285","journal-title":"Epigenetics"},{"key":"2844_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/jnc.14999","volume":"154","author":"I Kaya","year":"2020","unstructured":"Kaya I, Jennische E, Lange S, Tarik Baykal A, Malmberg P, Fletcher JS (2020) Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer\u2019s disease mice. J Neurochem 154:84\u201398. https:\/\/doi.org\/10.1111\/jnc.14999","journal-title":"J Neurochem"},{"key":"2844_CR68","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al (2002) The human genome browser at UCSC. Genome Res 12:996\u20131006. https:\/\/doi.org\/10.1101\/gr.229102","journal-title":"Genome Res"},{"key":"2844_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimers Dement (N Y)"},{"key":"2844_CR70","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3233\/JAD-220360","volume":"88","author":"SH Krance","year":"2022","unstructured":"Krance SH, Wu CY, Chan ACY, Kwong S, Song BX, Xiong LY et al (2022) Endosomal-lysosomal and autophagy pathway in Alzheimer\u2019s Disease: a systematic review and meta-analysis. J Alzheimers Dis 88:1279\u20131292. https:\/\/doi.org\/10.3233\/JAD-220360","journal-title":"J Alzheimers Dis"},{"key":"2844_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00401-024-02767-1","volume":"148","author":"D Leitner","year":"2024","unstructured":"Leitner D, Kavanagh T, Kanshin E, Balcomb K, Pires G, Thierry M et al (2024) Differences in the cerebral amyloid angiopathy proteome in Alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol 148:9. https:\/\/doi.org\/10.1007\/s00401-024-02767-1","journal-title":"Acta Neuropathol"},{"key":"2844_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-024-02683-4","volume":"147","author":"D Leitner","year":"2024","unstructured":"Leitner D, Pires G, Kavanagh T, Kanshin E, Askenazi M, Ueberheide B et al (2024) Similar brain proteomic signatures in Alzheimer\u2019s disease and epilepsy. Acta Neuropathol 147:27. https:\/\/doi.org\/10.1007\/s00401-024-02683-4","journal-title":"Acta Neuropathol"},{"key":"2844_CR73","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.brainres.2009.08.072","volume":"1298","author":"EC Levin","year":"2009","unstructured":"Levin EC, Acharya NK, Sedeyn JC, Venkataraman V, D\u2019Andrea MR, Wang HY et al (2009) Neuronal expression of vimentin in the Alzheimer\u2019s disease brain may be part of a generalized dendritic damage-response mechanism. Brain Res 1298:194\u2013207. https:\/\/doi.org\/10.1016\/j.brainres.2009.08.072","journal-title":"Brain Res"},{"key":"2844_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101669","author":"Y Levites","year":"2024","unstructured":"Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M et al (2024) Integrative proteomics identifies a conserved Abeta amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer\u2019s disease. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101669","journal-title":"Cell Rep Med"},{"key":"2844_CR75","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/039463200501800117","volume":"18","author":"F Licastro","year":"2005","unstructured":"Licastro F, Chiappelli M, Ruscica M, Carnelli V, Corsi MM (2005) Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer\u2019s type. Int J Immunopathol Pharmacol 18:165\u2013172. https:\/\/doi.org\/10.1177\/039463200501800117","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2844_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add8856","author":"PY Lin","year":"2023","unstructured":"Lin PY, Chen LY, Jiang M, Trotter JH, Seigneur E, Sudhof TC (2023) Neurexin-2: an inhibitory neurexin that restricts excitatory synapse formation in the hippocampus. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.add8856","journal-title":"Sci Adv"},{"key":"2844_CR77","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/cdd.2008.191","volume":"16","author":"FC Lourenco","year":"2009","unstructured":"Lourenco FC, Galvan V, Fombonne J, Corset V, Llambi F, Muller U et al (2009) Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death Differ 16:655\u2013663. https:\/\/doi.org\/10.1038\/cdd.2008.191","journal-title":"Cell Death Differ"},{"key":"2844_CR78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0169-328x(90)90032-9","volume":"7","author":"WJ Lukiw","year":"1990","unstructured":"Lukiw WJ, Crapper McLachlan DR (1990) Chromatin structure and gene expression in Alzheimer\u2019s disease. Brain Res Mol Brain Res 7:227\u2013233. https:\/\/doi.org\/10.1016\/0169-328x(90)90032-9","journal-title":"Brain Res Mol Brain Res"},{"key":"2844_CR79","doi-asserted-by":"publisher","first-page":"1341141","DOI":"10.3389\/fncel.2024.1341141","volume":"18","author":"JL Martinez","year":"2024","unstructured":"Martinez JL, Piciw JG, Crockett M, Sorci IA, Makwana N, Sirois CL et al (2024) Transcriptional consequences of trisomy 21 on neural induction. Front Cell Neurosci 18:1341141. https:\/\/doi.org\/10.3389\/fncel.2024.1341141","journal-title":"Front Cell Neurosci"},{"key":"2844_CR80","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ et al (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570:332\u2013337. https:\/\/doi.org\/10.1038\/s41586-019-1195-2","journal-title":"Nature"},{"key":"2844_CR81","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.174.269","volume":"174","author":"PL McGeer","year":"1994","unstructured":"McGeer PL, Klegeris A, Walker DG, Yasuhara O, McGeer EG (1994) Pathological proteins in senile plaques. Tohoku J Exp Med 174:269\u2013277. https:\/\/doi.org\/10.1620\/tjem.174.269","journal-title":"Tohoku J Exp Med"},{"issue":"116\u2013130","key":"2844_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.12.002","volume":"29","author":"HS Meharena","year":"2022","unstructured":"Meharena HS, Marco A, Dileep V, Lockshin ER, Akatsu GY, Mullahoo J et al (2022) Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. Cell Stem Cell 29(116\u2013130):e117. https:\/\/doi.org\/10.1016\/j.stem.2021.12.002","journal-title":"Cell Stem Cell"},{"key":"2844_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.824922","author":"N Mollo","year":"2022","unstructured":"Mollo N, Aurilia M, Scognamiglio R, Zerillo L, Cicatiello R, Bonfiglio F et al (2022) Overexpression of the Hsa21 Transcription Factor RUNX1 Modulates the Extracellular Matrix in Trisomy 21 Cells. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2022.824922","journal-title":"Front Genet"},{"key":"2844_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2844_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-4-1","volume":"4","author":"H Muramatsu","year":"2011","unstructured":"Muramatsu H, Yokoi K, Chen L, Ichihara-Tanaka K, Kimura T, Muramatsu T (2011) Midkine as a factor to counteract the deposition of amyloid beta-peptide plaques: in vitro analysis and examination in knockout mice. Int Arch Med 4:1. https:\/\/doi.org\/10.1186\/1755-7682-4-1","journal-title":"Int Arch Med"},{"key":"2844_CR86","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA (2017) Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J 31:2729\u20132743. https:\/\/doi.org\/10.1096\/fj.201700359","journal-title":"FASEB J"},{"key":"2844_CR87","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX et al (2021) Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun 12:1610. https:\/\/doi.org\/10.1038\/s41467-021-21823-y","journal-title":"Nat Commun"},{"key":"2844_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051275","author":"SY Park","year":"2020","unstructured":"Park SY, Kang JY, Lee T, Nam D, Jeon CJ, Kim JB (2020) SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer\u2019s Disease mouse model. Cells. https:\/\/doi.org\/10.3390\/cells9051275","journal-title":"Cells"},{"key":"2844_CR89","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1093\/emboj\/19.23.6392","volume":"19","author":"SA Paschen","year":"2000","unstructured":"Paschen SA, Rothbauer U, Kaldi K, Bauer MF, Neupert W, Brunner M (2000) The role of the TIM8-13 complex in the import of Tim23 into mitochondria. EMBO J 19:6392\u20136400. https:\/\/doi.org\/10.1093\/emboj\/19.23.6392","journal-title":"EMBO J"},{"key":"2844_CR90","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jnr.490300411","volume":"30","author":"LS Perlmutter","year":"1991","unstructured":"Perlmutter LS, Barron E, Saperia D, Chui HC (1991) Association between vascular basement membrane components and the lesions of Alzheimer\u2019s disease. J Neurosci Res 30:673\u2013681. https:\/\/doi.org\/10.1002\/jnr.490300411","journal-title":"J Neurosci Res"},{"key":"2844_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/724904","author":"M Perluigi","year":"2012","unstructured":"Perluigi M, Butterfield DA (2012) Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res. https:\/\/doi.org\/10.1155\/2012\/724904","journal-title":"Curr Gerontol Geriatr Res"},{"key":"2844_CR92","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1073\/pnas.0606137103","volume":"103","author":"M Poet","year":"2006","unstructured":"Poet M, Kornak U, Schweizer M, Zdebik AA, Scheel O, Hoelter S et al (2006) Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. Proc Natl Acad Sci U S A 103:13854\u201313859. https:\/\/doi.org\/10.1073\/pnas.0606137103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR93","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/156720501301151207100616","volume":"13","author":"H Potter","year":"2016","unstructured":"Potter H, Granic A, Caneus J (2016) Role of trisomy 21 mosaicism in sporadic and familial Alzheimer\u2019s disease. Curr Alzheimer Res 13:7\u201317. https:\/\/doi.org\/10.2174\/156720501301151207100616","journal-title":"Curr Alzheimer Res"},{"key":"2844_CR94","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC et al (1998) Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome. Ann Neurol 43:380\u2013383. https:\/\/doi.org\/10.1002\/ana.410430316","journal-title":"Ann Neurol"},{"key":"2844_CR95","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/NEN.0b013e3181ffe742","volume":"69","author":"SN Pressey","year":"2010","unstructured":"Pressey SN, O\u2019Donnell KJ, Stauber T, Fuhrmann JC, Tyynela J, Jentsch TJ et al (2010) Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7\/Ostm1. J Neuropathol Exp Neurol 69:1228\u20131246. https:\/\/doi.org\/10.1097\/NEN.0b013e3181ffe742","journal-title":"J Neuropathol Exp Neurol"},{"key":"2844_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031259","volume-title":"Nuclear Reorganization in Hippocampal Granule Cell Neurons from a Mouse Model of Down Syndrome: Changes in Chromatin Configuration","author":"A Puente-Bedia","year":"2021","unstructured":"Puente-Bedia A, Berciano MT, Tapia O, Martinez-Cue C, Lafarga M, Rueda N (2021) Nuclear Reorganization in Hippocampal Granule Cell Neurons from a Mouse Model of Down Syndrome: Changes in Chromatin Configuration. Int J Mol Sci, Nucleoli and Cajal Bodies. https:\/\/doi.org\/10.3390\/ijms22031259"},{"key":"2844_CR97","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang W, Yau WM, Lu JX, Collinge J, Tycko R (2017) Structural variation in amyloid-beta fibrils from Alzheimer\u2019s disease clinical subtypes. Nature 541:217\u2013221. https:\/\/doi.org\/10.1038\/nature20814","journal-title":"Nature"},{"key":"2844_CR98","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C (2021) Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener 16:59. https:\/\/doi.org\/10.1186\/s13024-021-00465-0","journal-title":"Mol Neurodegener"},{"issue":"1452\u20131468","key":"2844_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2021.03.032","volume":"56","author":"JC Roney","year":"2021","unstructured":"Roney JC, Li S, Farfel-Becker T, Huang N, Sun T, Xie Y et al (2021) Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C. Dev Cell 56(1452\u20131468):e1458. https:\/\/doi.org\/10.1016\/j.devcel.2021.03.032","journal-title":"Dev Cell"},{"key":"2844_CR100","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.devcel.2011.10.007","volume":"21","author":"C Rosa-Ferreira","year":"2011","unstructured":"Rosa-Ferreira C, Munro S (2011) Arl8 and SKIP act together to link lysosomes to kinesin-1. Dev Cell 21:1171\u20131178. https:\/\/doi.org\/10.1016\/j.devcel.2011.10.007","journal-title":"Dev Cell"},{"issue":"1788\u20131805","key":"2844_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O\u2019Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA (2022) Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron 110(1788\u20131805):e1710. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.008","journal-title":"Neuron"},{"key":"2844_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.908413","author":"F Saini","year":"2022","unstructured":"Saini F, Dell\u2019Acqua F, Strydom A (2022) Structural connectivity in Down Syndrome and Alzheimer\u2019s Disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2022.908413","journal-title":"Front Neurosci"},{"key":"2844_CR103","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41598-021-85494-x","volume":"11","author":"C Sassi","year":"2021","unstructured":"Sassi C, Capozzo R, Hammer M, Zecca C, Federoff M, Blauwendraat C et al (2021) Exploring dementia and neuronal ceroid lipofuscinosis genes in 100 FTD-like patients from 6 towns and rural villages on the Adriatic Sea cost of Apulia. Sci Rep 11:6353. https:\/\/doi.org\/10.1038\/s41598-021-85494-x","journal-title":"Sci Rep"},{"key":"2844_CR104","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0092-8674(94)90420-0","volume":"78","author":"T Serafini","year":"1994","unstructured":"Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM, Tessier-Lavigne M (1994) The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78:409\u2013424. https:\/\/doi.org\/10.1016\/0092-8674(94)90420-0","journal-title":"Cell"},{"key":"2844_CR105","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D et al (1992) Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids. Nature 359:325\u2013327. https:\/\/doi.org\/10.1038\/359325a0","journal-title":"Nature"},{"key":"2844_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2016.11.006","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L et al (2017) A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer\u2019s Disease. Cell Syst. https:\/\/doi.org\/10.1016\/j.cels.2016.11.006","journal-title":"Cell Syst"},{"key":"2844_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413647","author":"A Shah","year":"2021","unstructured":"Shah A, Kishore U, Shastri A (2021) Complement system in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222413647","journal-title":"Int J Mol Sci"},{"key":"2844_CR108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-021-00464-1","volume":"16","author":"MG Sharoar","year":"2021","unstructured":"Sharoar MG, Palko S, Ge Y, Saido TC, Yan R (2021) Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer\u2019s disease brains. Mol Neurodegener 16:45. https:\/\/doi.org\/10.1186\/s13024-021-00464-1","journal-title":"Mol Neurodegener"},{"key":"2844_CR109","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/alz.12112","volume":"16","author":"HM Snyder","year":"2020","unstructured":"Snyder HM, Bain LJ, Brickman AM, Carrillo MC, Esbensen AJ, Espinosa JM et al (2020) Further understanding the connection between Alzheimer\u2019s disease and Down syndrome. Alzheimers Dement 16:1065\u20131077. https:\/\/doi.org\/10.1002\/alz.12112","journal-title":"Alzheimers Dement"},{"key":"2844_CR110","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1073\/pnas.1719808115","volume":"115","author":"S Sole-Domenech","year":"2018","unstructured":"Sole-Domenech S, Rojas AV, Maisuradze GG, Scheraga HA, Lobel P, Maxfield FR (2018) Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Abeta by multiple endoproteolytic cleavages within the beta-sheet domain. Proc Natl Acad Sci U S A 115:1493\u20131498. https:\/\/doi.org\/10.1073\/pnas.1719808115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2844_CR111","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-151046","volume":"52","author":"PR Spilman","year":"2016","unstructured":"Spilman PR, Corset V, Gorostiza O, Poksay KS, Galvan V, Zhang J et al (2016) Netrin-1 interrupts amyloid-beta amplification, increases sAbetaPPalpha in vitro and in vivo, and improves cognition in a mouse model of Alzheimer\u2019s Disease. J Alzheimers Dis 52:223\u2013242. https:\/\/doi.org\/10.3233\/JAD-151046","journal-title":"J Alzheimers Dis"},{"key":"2844_CR112","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13073-021-00959-y","volume":"13","author":"Y Sun","year":"2021","unstructured":"Sun Y, Zhu J, Zhou D, Canchi S, Wu C, Cox NJ et al (2021) A transcriptome-wide association study of Alzheimer\u2019s disease using prediction models of relevant tissues identifies novel candidate susceptibility genes. Genome Med 13:141. https:\/\/doi.org\/10.1186\/s13073-021-00959-y","journal-title":"Genome Med"},{"key":"2844_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105576","author":"MP Szabo","year":"2022","unstructured":"Szabo MP, Mishra S, Knupp A, Young JE (2022) The role of Alzheimer\u2019s disease risk genes in endolysosomal pathways. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2021.105576","journal-title":"Neurobiol Dis"},{"key":"2844_CR114","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S et al (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49:D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074","journal-title":"Nucleic Acids Res"},{"key":"2844_CR115","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66290","author":"H Tachiwana","year":"2021","unstructured":"Tachiwana H, Dacher M, Maehara K, Harada A, Seto Y, Katayama R et al (2021) Chromatin structure-dependent histone incorporation revealed by a genome-wide deposition assay. Elife. https:\/\/doi.org\/10.7554\/eLife.66290","journal-title":"Elife"},{"key":"2844_CR116","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/s0002-9440(10)64463-x","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H et al (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161:1869\u20131879. https:\/\/doi.org\/10.1016\/s0002-9440(10)64463-x","journal-title":"Am J Pathol"},{"key":"2844_CR117","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"2844_CR118","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10048-009-0201-5","volume":"11","author":"Y Tong","year":"2010","unstructured":"Tong Y, Xu Y, Scearce-Levie K, Ptacek LJ, Fu YH (2010) COL25A1 triggers and promotes Alzheimer\u2019s disease-like pathology in vivo. Neurogenetics 11:41\u201352. https:\/\/doi.org\/10.1007\/s10048-009-0201-5","journal-title":"Neurogenetics"},{"key":"2844_CR119","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731\u2013740. https:\/\/doi.org\/10.1038\/nmeth.3901","journal-title":"Nat Methods"},{"key":"2844_CR120","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/hmg\/dds109","volume":"21","author":"A Vagnoni","year":"2012","unstructured":"Vagnoni A, Perkinton MS, Gray EH, Francis PT, Noble W, Miller CC (2012) Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Abeta production. Hum Mol Genet 21:2845\u20132854. https:\/\/doi.org\/10.1093\/hmg\/dds109","journal-title":"Hum Mol Genet"},{"key":"2844_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.884020","author":"S Vats","year":"2022","unstructured":"Vats S, Galli T (2022) Role of SNAREs in unconventional secretion-focus on the VAMP7-dependent secretion. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.884020","journal-title":"Front Cell Dev Biol"},{"key":"2844_CR122","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-020-00598-2","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang X, Song Q, Hou Y, Liu J, Sun Y et al (2020) Characterization of the chromatin accessibility in an Alzheimer\u2019s disease (AD) mouse model. Alzheimers Res Ther 12:29. https:\/\/doi.org\/10.1186\/s13195-020-00598-2","journal-title":"Alzheimers Res Ther"},{"key":"2844_CR123","doi-asserted-by":"publisher","first-page":"20511","DOI":"10.1038\/s41598-021-99352-3","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang Q, Lin JR, Jabalameli MR, Mitra J, Nguyen N et al (2021) Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer\u2019s disease, providing new insights into its disease mechanisms. Sci Rep 11:20511. https:\/\/doi.org\/10.1038\/s41598-021-99352-3","journal-title":"Sci Rep"},{"key":"2844_CR124","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12017-020-08612-4","volume":"22","author":"ZX Wang","year":"2020","unstructured":"Wang ZX, Wan Q, Xing A (2020) HLA in Alzheimer\u2019s Disease: genetic association and possible pathogenic roles. Neuromolecular Med 22:464\u2013473. https:\/\/doi.org\/10.1007\/s12017-020-08612-4","journal-title":"Neuromolecular Med"},{"key":"2844_CR125","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1096\/fj.03-1040fje","volume":"18","author":"N Watanabe","year":"2004","unstructured":"Watanabe N, Araki W, Chui DH, Makifuchi T, Ihara Y, Tabira T (2004) Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer\u2019s disease. FASEB J 18:1013\u20131015. https:\/\/doi.org\/10.1096\/fj.03-1040fje","journal-title":"FASEB J"},{"key":"2844_CR126","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"A Webers","year":"2020","unstructured":"Webers A, Heneka MT, Gleeson PA (2020) The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease. Immunol Cell Biol 98:28\u201341. https:\/\/doi.org\/10.1111\/imcb.12301","journal-title":"Immunol Cell Biol"},{"key":"2844_CR127","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","volume":"70","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang KC et al (2011) Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. J Neuropathol Exp Neurol 70:36\u201350. https:\/\/doi.org\/10.1097\/NEN.0b013e318202bfa1","journal-title":"J Neuropathol Exp Neurol"},{"issue":"297","key":"2844_CR128","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/j.urolonc.2019.01.011","volume":"37","author":"Y Wen","year":"2019","unstructured":"Wen Y, An Z, Qiao B, Zhang C, Zhang Z (2019) RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer. Urol Oncol 37(297):e291-297. https:\/\/doi.org\/10.1016\/j.urolonc.2019.01.011","journal-title":"Urol Oncol"},{"key":"2844_CR129","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awy159","volume":"141","author":"FK Wiseman","year":"2018","unstructured":"Wiseman FK, Pulford LJ, Barkus C, Liao F, Portelius E, Webb R et al (2018) Trisomy of human chromosome 21 enhances amyloid-beta deposition independently of an extra copy of APP. Brain 141:2457\u20132474. https:\/\/doi.org\/10.1093\/brain\/awy159","journal-title":"Brain"},{"key":"2844_CR130","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","volume":"85","author":"T Wisniewski","year":"2015","unstructured":"Wisniewski T, Goni F (2015) Immunotherapeutic approaches for Alzheimer\u2019s disease. Neuron 85:1162\u20131176. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.064","journal-title":"Neuron"},{"key":"2844_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.07.060","author":"T Wu","year":"2019","unstructured":"Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S et al (2019) Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.060","journal-title":"Cell Rep"},{"key":"2844_CR132","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.12122\/j.issn.1673-4254.2021.12.01","volume":"41","author":"J Xue","year":"2021","unstructured":"Xue J, Liu J, Geng M, Yue J, He H, Fan J (2021) Identification of potential hub genes of Alzheimer\u2019s disease by weighted gene co-expression network analysis. Nan Fang Yi Ke Da Xue Xue Bao 41:1752\u20131762. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2021.12.01","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2844_CR133","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/jb\/mvw067","volume":"161","author":"Y Yoshimura","year":"2017","unstructured":"Yoshimura Y, Araki A, Maruta H, Takahashi Y, Yamashita H (2017) Molecular cloning of rat acss3 and characterization of mammalian propionyl-CoA synthetase in the liver mitochondrial matrix. J Biochem 161:279\u2013289. https:\/\/doi.org\/10.1093\/jb\/mvw067","journal-title":"J Biochem"},{"key":"2844_CR134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35024009","volume":"407","author":"G Yu","year":"2000","unstructured":"Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A et al (2000) Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing. Nature 407:48\u201354. https:\/\/doi.org\/10.1038\/35024009","journal-title":"Nature"},{"key":"2844_CR135","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaneurol.2014.3049","volume":"72","author":"L Yu","year":"2015","unstructured":"Yu L, Chibnik LB, Srivastava GP, Pochet N, Yang J, Xu J et al (2015) Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol 72:15\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3049","journal-title":"JAMA Neurol"},{"key":"2844_CR136","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3233\/JAD-142013","volume":"44","author":"X Zhan","year":"2015","unstructured":"Zhan X, Jickling GC, Ander BP, Stamova B, Liu D, Kao PF et al (2015) Myelin basic protein associates with AbetaPP, Abeta1-42, and amyloid plaques in cortex of Alzheimer\u2019s disease brain. J Alzheimers Dis 44:1213\u20131229. https:\/\/doi.org\/10.3233\/JAD-142013","journal-title":"J Alzheimers Dis"},{"key":"2844_CR137","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1128","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. https:\/\/doi.org\/10.2202\/1544-6115.1128","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2844_CR138","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.2200863","volume":"211","author":"H Zhang","year":"2023","unstructured":"Zhang H, Meng L, Liu Y, Jiang J, He Z, Qin J et al (2023) Sfxn5 regulation of actin polymerization for neutrophil spreading depends on a citrate-cholesterol-PI(4,5)P2 pathway. J Immunol 211:462\u2013473. https:\/\/doi.org\/10.4049\/jimmunol.2200863","journal-title":"J Immunol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02844-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T17:38:42Z","timestamp":1737221922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02844-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2844"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02844-z","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.F. reported receiving personal fees for service on the advisory boards, adjudication committees or speaker honoraria from AC Immune, Adamed, Alzheon, Biogen, Eisai, Esteve, Fujirebio, Ionis, Laboratorios Carnot, Life Molecular Imaging, Lilly, Lundbeck, Novo Nordisk, Perha, Roche, Zamb\u00f3n and outside the submitted work. J.F. reports holding a patent for markers of synaptopathy in neurodegenerative disease (licensed to ADx, EPI8382175.0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"9"}}